Brandywine Global Investment Management’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-102,969
Closed -$7.71M – 698
2023
Q4
$7.71M Sell
102,969
-10,659
-9% -$763K 0.06% 302
2023
Q3
$9.68M Sell
113,628
-1,792
-2% -$170K 0.08% 239
2023
Q2
$12.6M Buy
115,420
+79
+0.1% +$7.49K 0.1% 196
2023
Q1
$9.57M Buy
+115,341
New +$10.9M 0.08% 246
2018
Q1
– Sell
-161,644
Closed -$7.96M – 893
2017
Q4
$7.96M Sell
161,644
-23,401
-13% -$1.07M 0.05% 336
2017
Q3
$8.46M Buy
185,045
+4,471
+2% +$171K 0.05% 320
2017
Q2
$7.05M Sell
180,574
-2,977
-2% -$114K 0.05% 363
2017
Q1
$7.45M Buy
183,551
+1,914
+1% +$75K 0.05% 351
2016
Q4
$6.98M Buy
+181,637
New +$6.21M 0.04% 363

Other funds holding AMN

Brandywine Global Investment Management's AMN Position: Q1 2024 in Review

Brandywine Global Investment Management sold out of AMN Healthcare (AMN) in Q1 2024, closing a stake of 102,969 shares — an estimated $7.71M sold.

Brandywine Global Investment Management first reported a position in AMN in Q4 2016 and held it in 9 quarters. The position peaked at $12.6M in Q2 2023. 347 funds tracked by Wall St. Rank hold AMN as of Q1 2024.

  • Brandywine Global Investment Management reported no remaining AMN Healthcare position as of Q1 2024 after selling out during the quarter.
  • Brandywine Global Investment Management sold 102,969 AMN Healthcare shares in Q1 2024, an estimated $7.71M.
  • Brandywine Global Investment Management first reported a position in AMN Healthcare in Q4 2016 and held it in 9 quarters.
  • Brandywine Global Investment Management's AMN Healthcare position peaked at $12.6M in Q2 2023.
  • 347 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2024.

Based on Brandywine Global Investment Management's 13F filing for Q1 2024, filed 13 May 2024.